Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial
about
Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial
description
scientific article published on 20 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Investigating the effects of n ...... lacebo-controlled INMARK®trial
@en
Investigating the effects of n ...... lacebo-controlled INMARK®trial
@nl
type
label
Investigating the effects of n ...... lacebo-controlled INMARK®trial
@en
Investigating the effects of n ...... lacebo-controlled INMARK®trial
@nl
prefLabel
Investigating the effects of n ...... lacebo-controlled INMARK®trial
@en
Investigating the effects of n ...... lacebo-controlled INMARK®trial
@nl
P2093
P2860
P1476
Investigating the effects of n ...... lacebo-controlled INMARK®trial
@en
P2093
Claudia Diefenbach
Daniel Wachtlin
Eric S White
Moisés Selman
R Gisli Jenkins
Susanne Stowasser
Vincent Cottin
Yasuhiko Nishioka
Zuzana Blahova
P2860
P304
P356
10.1136/BMJRESP-2018-000325
P407
P50
P577
2018-08-20T00:00:00Z